<DOC>
	<DOCNO>NCT00247117</DOCNO>
	<brief_summary>The purpose study examine effect metformin biochemical histological finding NAFLD patient insulin resistance syndrome .</brief_summary>
	<brief_title>Metformin Patients With Non-Alcoholic Fatty Liver Disease ( NAFLD )</brief_title>
	<detailed_description>Study population : 30 patient included meet follow criterion : ALT &gt; 2 time normal range ; liver histology reveal NASH ( type 2-4 ) , without cirrhosis ; clinical characteristic metabolic syndrome define NCEP , overt diabetes ; negative work-up cause liver disease include alcohol intake &lt; 40 g/week . All patient undergo liver biopsy patient type 2-4 ( steatosis + inflammation , steatosis plus ballooning degeneration , steatosis plus fibrosis and/or Mallory body ) without cirrhosis include . Patients receive lipid lower medication anti hypertensive drug prior study continue treatment . Patients develop overt type 2 DM HbAic &gt; 7 % study withdrawn . Intervention : All patient dietary intervention dietician encourage increase physical activity . Patients receive metformin 850 mg tid 12 month . Outcome : - Improvement liver enzyme ( ALT , AST , GGT ) - Improvement metabolic profile : lipid profile , fast post-load glucose insulin level , HOMA . - Liver histology ( repeat liver biopsy 1 year ) . - Soluble TNF receptors- TNF-receptor P55 P75 .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>ALT &gt; 2 time normal range . Liver histology reveal nonalcoholic steatohepatitis [ NASH ] ( type 24 ) , without cirrhosis . Clinical characteristic metabolic syndrome define National Cholesterol Education Program ( NCEP ) , overt diabetes . Negative workup cause liver disease include alcohol intake &lt; 40 g/week . Diabetes mellitus . Alcohol intake &gt; 40 g per week .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2003</verification_date>
	<keyword>non-alcoholic fatty liver disease</keyword>
	<keyword>insulin resistance</keyword>
	<keyword>metformin</keyword>
</DOC>